Skip to content
Search

Latest Stories

GPhC appoints Gisela Abbam as its new chair

General Pharmaceutical Council (GPhC) has appointed Gisela Abbam as its new chair.

Appointment of Abbam, who will assume office on March 14, 2022, was made by the Privy Council after a robust selection process which was scrutinised by the Professional Standards Authority.


She will take over from the current chair, Nigel Clarke, who has been in position since 2014 and has completed the statutory maximum eight years in office.

Commenting on her appointment, Abbam said: "I am delighted and honoured to be appointed as the new chair of the General Pharmaceutical Council and I look forward to leading the Council to achieve its vision of safe and effective pharmacy care at the heart of healthier communities.

“Covid-19 highlighted the increased role of pharmacists, pharmacy technicians and pharmacies in providing clinical services. Effective standards and regulation can help pharmacy to provide more support to patients and the public at large. I look forward to working with Council, the Executive team and staff and collaborating with other organisations to improve the health of people using pharmacy services."

Welcoming Abbam to the Council, Clarke, said: “Gisela is joining the GPhC at an exciting time of major changes in both pharmacy and health regulation. I am sure her vast experience in healthcare will help the GPhC drive forward the aims set out in our Vision 2030, and bring a real focus on the difference we want to make for patients and the public.”

Previously, Abbam was chair of the British Science Association (BSA). During her tenure, she led the BSA’s Council and championed the BSA mission and vision, driving forward an agenda on equality, diversity, and inclusion in STEM (Science, Technology, Engineering and Maths).

She has worked in collaboration with governments, the World Health Organisation, the United Nations, and other multilateral organisations to improve health outcomes for people across the world.

She is also the senior director government affairs for EMEAI at PerkinElmer, a global provider of end-to-end solutions that help scientists, researchers and clinicians better diagnose disease, discover new and more personalised drugs, monitor the safety and quality of food.

Besides, she serves on a number of advisory committees and sits on the Board of Everywoman Ltd., an organisation dedicated to advancing women in business.

Many in the industry congratulated the Council on the new appointment.

Welcoming the new GPhC chair, Mark Lyonette, chief executive of National Pharmacy Association wrote on twitter, “looking forward to meeting @gmabbam once she starts.

Mark tweet

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Dr Penelope Dash new chair of NHS England

Dr Penny Dash is currently the chair of the NHS North West London Integrated Care Board

parliamentlive

Dr Penelope Dash appointed as new chair of NHS England

Dr Penny Dash has been appointed as the next chair of NHS England following an open public appointment process.

She will succeed Richard Meddings, who is set to step down next month, and her four-year term begins on April 1, 2025.

Keep ReadingShow less